Ervogastat
| Supplier | MedChemExpress |
|---|---|
| Product # | HY-111620-50 mg |
| CAS # | 2186700-33-2 |
| Pricing | 50 mg, USD $1700.0 |
| Synonyms | PF-06865571 |
| MWt | 407.42 |
| Formula | C₂₁H₂₁N₅O₄ |
| Biological Activity | Ervogastat (PF-06865571) is a potent and well-tolerated diacylglycerol acyltransferase 2 inhibitor (DGAT2i). Ervogastat alone reduces steatosis and hepatic triglyceride levels in non-alcoholic steatohepatitis (NASH)[1]. Ervogastat combination with Clesacostat (an acetyl CoA-carboxylase inhibitor (ACCi)) can be used for the research of NASH with liver fibrosis therapy[1][2]. |
| Purity | 98.97% |